Evidence map›Paper›PMID 27095765›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2016

[Risk factors for short-term outcome of patients with HBV-related acute-on-chronic liver failure].

C Li, S Lyu, B Zhu, Z H Wan, W S Liu, L Guo, S L You, S J Xin

Abstract read
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. [Discussion and evaluation of diagnostic criteria for hepatitis B virus-related acute-on-chronic pre-liver failure].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018
    Article
  3. [Relationship between bile acid metabolism and chronic non - cholestatic liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2018
    Article
  4. Article
  5. [Pathogenic features and prognosis of ventilator-associated pneumonia in patients with liver failure].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

C LiMedical School of PLA, Beijing 100853, China; Department of Liver Failure Treatment and Research Center, 302ed hospital of PLA, Beijing 100039, China.
S LyuDepartment of Liver Failure Treatment and Research Center, 302ed hospital of PLA, Beijing 100039, China.
B ZhuDepartment of Liver Failure Treatment and Research Center, 302ed hospital of PLA, Beijing 100039, China.
Z H WanDepartment of Liver Failure Treatment and Research Center, 302ed hospital of PLA, Beijing 100039, China.
W S LiuDepartment of Liver Failure Treatment and Research Center, 302ed hospital of PLA, Beijing 100039, China.
L GuoThe 61785ed Military Outpatient Department, Beijing 100075, China; Department of Liver Failure Treatment and Research Center, 302ed hospital of PLA, Beijing 100039, China.
S L YouDepartment of Liver Failure Treatment and Research Center, 302ed hospital of PLA, Beijing 100039, China.
S J XinMedical School of PLA, Beijing 100853, China; Department of Liver Failure Treatment and Research Center, 302ed hospital of PLA, Beijing 100039, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the risk factors for the short-term outcome of patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF), and to establish a risk model for predicting the short-term outcome of these patients.

methodsA total of 338 patients with HBV-related ACLF who were admitted to 30 Lod hospital of PLA hospital from January 2010 to January 2014 were enrolled, and a prospective clinical follow-up was performed for them. Multivariate logistic regression was used to determine the risk factors for short-term (12 weeks) outcome, the predictive model with logistic regression equation was established, and the predictive value of this model was evaluated.

resultsThe multivariate logistic regression analysis showed that age, a family history of hepatitis B, hepatic encephalopathy (HE), hepatorenal syndrome (HRS), white blood cell (WBC), platelet (PLT), international normalized ratio (INR), total bilirubin (TBil), total bile acid (TBA), creatinine, Na, HBV DNA, and HBeAg were the independent risk factors for the short-term outcome of these patients. Logistic(p) = -4.466 + 1.192 age + 1.631 family history of hepatitis B + 1.091 HE + 1.631 HRS + 1.208 WBC -1.487 PLT + 1.092 INR + 1.446 TBil + 1.608 TBA -1.101 CHE + 1.279 CRE -1.713 Na + 1.032 HBV DNA + 0.833 HBeAg. The area under the receiver operating characteristic curve of the model for the prediction of short-term outcome was 0.930, the cut-off value was 3.16, the sensitivity was 0.860, and the specificity was 0.871. With the increasing scores of the equation, the mortality of patients tended to increase gradually.

conclusionAge, a family history of hepatitis B, HE, HRS, WBC, PLT, INR, TBil, TBA, CHE, CRE, Na, HBV DNA, and HBeAg are the independent risk factors for the short-term outcome of patients with HBV-related ACLF. The model for predicting short-term outcome established on the basis of independent risk factors has a better clinical value in guiding clinical therapy.

Indexed as

Hepatitis B virusAcute-On-Chronic Liver FailureAdultBilirubinFemaleHepatitis BHepatitis B, ChronicHumansLiver FailureLogistic ModelsMaleMiddle AgedModels, TheoreticalMultivariate AnalysisPredictive Value of TestsPrognosisBilirubin

Identifiers

PMID27095765
PMCPMC12769520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.